Vimarsana
Biggest News Aggregation in the World

Page 7 - Precision Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Precision Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Precision Diagnostics Today - Breaking & Trending Today

Worldwide Fertility Test Industry to 2030 - by Product Type, Application, Mode of Purchase, End-user and Region - Vimarsana News

Worldwide Fertility Test Industry to 2030 - by Product Type, Application, Mode of Purchase, End-user and Region

/PRNewswire/ -- The "Fertility Test Market: Global Market Size, Forecast, Insights, and Competitive Landscape" report has been added to...

Nanotechnology Market Report: India - Vimarsana News

Nanotechnology Market Report: India

The nanotechnology market in India is expanding quickly, with numerous applications in the healthcare, consumer items, energy, and the military sector.

QIAGEN N.V.: QIAGEN receives FDA approval for companion diagnostic to Mirati Therapeutics' KRAZATI in non-small cell lung cancer - Vimarsana News

QIAGEN N.V.: QIAGEN receives FDA approval for companion diagnostic to Mirati Therapeutics' KRAZATI in non-small cell lung cancer

therascreenKRAS RGQ PCR kit approved as a companion diagnostic to aid in identifying non-small cell lung cancer (NSCLC) patients eligible for treatment with KRAZATI (adagrasib) KRAS mutations

QIAGEN receives FDA approval for companion diagnostic to Mirati Therapeutics' KRAZATI in non-small cell lung cancer Seite 1 - Vimarsana News

QIAGEN receives FDA approval for companion diagnostic to Mirati Therapeutics' KRAZATI in non-small cell lung cancer Seite 1

13.12.2022 - QIAGEN (NYSE:QGEN; Frankfurt Prime Standard: QIA) has announced the U.S. Food and Drug Administration (FDA) approval of its therascreen KRAS RGQ PCR kit (therascreen KRAS kit) as a companion diagnostic test to Mirati Therapeutic’s drug KRAZATI ... Seite 1

Oncology Precision Medicine Market Report 2022: Increasing Risk of Chronic Diseases in Geriatric Population Drives Growth - Vimarsana News

Oncology Precision Medicine Market Report 2022: Increasing Risk of Chronic Diseases in Geriatric Population Drives Growth

/PRNewswire/ -- The "Oncology Precision Medicine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 By Ecosystem, By...